暗記メーカー

暗記メーカー

​
ログイン
gastro
100問 • 2年前
  • Hannah Angelique Losaria
    • 通報

    問題一覧

  • 1

    gi transit, speed gastric emptying time

    prokinetic

  • 2

    prokinetic indications

    GERD, impaired gastric emptying, vagotomy, antrectomy, diabetic gastroperesis

  • 3

    cholinomimetic agents

    betanechol, neostigmine

  • 4

    muscarinic m3 receptor on myenteric plexus synapse

    betanechol

  • 5

    acetylcholinisterase inhibitor, ohilvie's syndrome

    neostigmine

  • 6

    acute colonic pseudoobstruction

    ogilvie's syndrome

  • 7

    substituted benzamines

    metoclopramide, domperidone, cisapride, erythromycin

  • 8

    blocks dopamine d2 receptor, anti nausea, antiemetic. includes prolactin, cholinergic smooth muscle stimulation

    metoclopramide, domperidone

  • 9

    methomoglobinemia

    metoclopramide

  • 10

    qt interval prolongation, cardiact arrest, sudden death

    domperidone

  • 11

    5ht4 agonist enteric neurons acetylcholine release 5ht3 antagonist

    cisapride

  • 12

    parkinsonism syndrome, restlessness

    metoclopramide

  • 13

    cardiac arrythmias

    cisapride

  • 14

    directly stimulates motilin receptor onset of migrating motor complex

    erythromycin

  • 15

    antipsychotic agents potent antiemetic and sedative properties inhibits dopamine and muscarinic antihistamine

    phenothiazine

  • 16

    dioperidol

    butyrophones

  • 17

    anti emetic due to dopaminergic blockade metoclopramide and trimethobenzamide dopamine receptor blockade

    butyrophones

  • 18

    lorazepam and diazepam

    benzodiazepines

  • 19

    before the initiation of cemotherapy to reduce anticipatory vomiting

    benzodiazepines

  • 20

    dronabinol

    cannabinoids

  • 21

    major psychoactive compound

    synthetic-9-tetrahydrocannabinoid

  • 22

    appetite stimulant

    cannabinoids

  • 23

    dexamethasone, methylprednisolone

    corticosteroids

  • 24

    tx of chemo induced vomiting

    corticosteroids

  • 25

    prototypic muscarinic receptor antagonist most effective for motion sickness

    hyoscine

  • 26

    prophylaxis of motion sickness clear for tetranogenic potential

    dicyclomine

  • 27

    h2 antihistamines

    cetirizine, cyclizine, dimehydrimate, diphenhydramine

  • 28

    motion sickness, lesser morning sickness anti emetic properties is base on anti cholinergic, anti histamine and sedation

    h2 antihistamines

  • 29

    potent antiemetics. blocks d2 receptor in ctz antagonize amorphin induced vomiting

    neuroleptics

  • 30

    difficult or infrequent passage of stools

    constipation

  • 31

    tx of constipations

    anticholinergic, antacid, narcotics

  • 32

    laxatives

    bulk forming, osmotic, stimulant, stool surfactant

  • 33

    indigestible, hydrophillic colloids that absorbs water forming or bulky emollient gels

    bulk laxatives

  • 34

    do not give to pc with crohns diseas, obstruction, intestinal strictures

    bulk laxatives

  • 35

    natural plant producs

    psylium and methylcellulose

  • 36

    synthetic fibers

    polycarbophil

  • 37

    soluble but not absorbable compound. results to increase stool liquidation

    saline and osmotic laxatives

  • 38

    purgatives

    magnesium citrate, sodium sulfate, milk of magnesia

  • 39

    magnesium oxide

    milk of magnesia

  • 40

    reduce ammonia levels in hepatic encephalopathy

    lactulose

  • 41

    rectal burning

    glycerin

  • 42

    sorbitol

    non absorbable

  • 43

    complete colonic cleansing before git endoscopy

    polythylene glycol

  • 44

    induce bowel movements through direct stimulation of enteric ns, colonic electrolyte, fluid secretion

    stimulant laxatives

  • 45

    not to be given in px with hpn, chf, and renal impairment

    saline

  • 46

    aloe, senna, cascara

    anthraquinone derivatives

  • 47

    side effects of anthraquinone derivatives

    melanosis coli, brown pigmentation, chronic use

  • 48

    diphenylmethane derivatives

    phenolphthalein, bisacodyl, castor oil

  • 49

    dulcolax

    bisacodyl

  • 50

    phased out in market due to cardiac toxicity

    phenolphthalein

  • 51

    hydrolyzed in small intestine local irritant that stimulates inyestinal motility

    castor oil

  • 52

    soften stool materials, permits h2o and lipides to penetrate

    stool surfactant agents

  • 53

    softeners

    stool surfactant agents

  • 54

    example of stool surfactants

    ducosate and glycerin supp

  • 55

    clear, viscous oil that lubricates fecal material

    mineral oil

  • 56

    cannot be given to patients with bloody diarrhea, fever, and systemic toxicity

    antidiarrheal

  • 57

    tx of fecal impaction and debilitated adults

    mineral oil

  • 58

    side effects of mineral oil

    aspiration, pneumonitis, impair absorption of fat-soluble vitamins

  • 59

    fat-soulble vitamins

    ADEK

  • 60

    mild to moderate acute diarrhea control diarrhea caused by IBS and IBD

    antidiarrheal

  • 61

    example of antidiarrheal

    opoiod anatgonist, kaolin and pectin, colloidal bismuth, ocreotide, bind salts and binding resins

  • 62

    examples of bile salt resins

    cholistyramine and colestipol

  • 63

    diarrhea caused by excess bile acids, crohn's disease and resection of terminal ileum

    cholistyramine

  • 64

    SE of bile salt resins

    bloating, flatulence, constipation, fecal impaction

  • 65

    half life of somatostatin

    3 minutes

  • 66

    half life of ocreotides

    1.5 hours

  • 67

    inhibits the secretion of gastrin, cholecystokinin, glucagon, growth hormone, insulin secretion, pancreatic polypeptide, vasoactive intestinal peptide, and 5ht3

    somatostatin and ocreotide

  • 68

    inhibition of endocrine tumor

    somatostatin and ocreotide

  • 69

    carceroid and VIPoma

    endocrine tumor

  • 70

    SE of somatostatin and ocreotide

    steatorrhea, abdominal pain, ADEK difficiency, nausea

  • 71

    blocks 5ht3 receptor in the affarebt neurons distention induced sensory and motor reflex activation colonic motility

    serotonin 5ht3 receptor antagonist

  • 72

    diarrhea predominant ibs

    serotonin 5ht3 receptor antagonist

  • 73

    adr of serotonin 5htr receptor antagonist

    constipation, ischemic collitis

  • 74

    inhibits muscarinic cholinergic receptor in the enteric plexus; smooth muscles

    antispasmodics

  • 75

    examples of antispasmodics

    dicyclomine, hyoscyamine, tegaserod

  • 76

    hyosyamine

    levsin

  • 77

    dicyclomine

    bentyl

  • 78

    resembles serotonin in structure

    tegaserod

  • 79

    tx for IBS with predominant constipation

    tegaserod

  • 80

    IBD

    inflammatory bowel disease

  • 81

    immune mediated chronic intestinal condition

    inflammatory bowel disease

  • 82

    backwash ileitis

    ulcerative colitis

  • 83

    involves the rectum, extends proximally to involve the colon

    ulcerative colitis

  • 84

    mouth to anus; rectum is spared

    crohn's disease

  • 85

    perirectal fistulas, fissures abscesses, anal stenosis

    crohn's disease

  • 86

    tx for crohn's disease

    aminosalicylates, azo compounds, mesalamine compounds

  • 87

    purine anti metabolite

    azathioprine and 6-mercaptopurine

  • 88

    glucocorticoids

    infliximab, tacrolimus, cyclosporine

  • 89

    mainstay of therapy for mild to moderate ulcerative colitis

    aminosalicylates

  • 90

    examples of azo compounds

    sulfasalazine, olsalazine, balsalazide

  • 91

    mesalamine compounds

    pentasa, asacol, rowasa

  • 92

    reduces absorption of the oarent drug from the small intestine

    azo compounds

  • 93

    resident bacteria cleanse the azo bonds by means of

    azoreductase enzyme

  • 94

    5 asa group are bound together

    sulfasalazine

  • 95

    bound to 4-aminobenzoyl-b-alanine secretory diarrhea

    olsalazine

  • 96

    contains time release microgranules

    pentasa

  • 97

    oated in ph-sensitive resinthat dissolves at ph7

    asacol

  • 98

    delivered at high concentration to the rectum and the sigmoid colon

    rowasa

  • 99

    side effect of mesalamin compounds

    entestinal nephritis

  • 100

    induction and maintenance of remission of UC and CD post operative prophylaxis of cd

    purine anti-metabolite

    • gastro m

    gastro m

    Hannah Angelique Losaria · 7問 · 2年前

    gastro m

    gastro m

    7問 • 2年前
    Hannah Angelique Losaria

    lab

    lab

    Hannah Angelique Losaria · 13問 · 2年前

    lab

    lab

    13問 • 2年前
    Hannah Angelique Losaria

    m2

    m2

    Hannah Angelique Losaria · 94問 · 2年前

    m2

    m2

    94問 • 2年前
    Hannah Angelique Losaria

    m1

    m1

    Hannah Angelique Losaria · 88問 · 2年前

    m1

    m1

    88問 • 2年前
    Hannah Angelique Losaria

    poisons

    poisons

    Hannah Angelique Losaria · 50問 · 1年前

    poisons

    poisons

    50問 • 1年前
    Hannah Angelique Losaria

    lec

    lec

    Hannah Angelique Losaria · 19問 · 1年前

    lec

    lec

    19問 • 1年前
    Hannah Angelique Losaria

    exam

    exam

    Hannah Angelique Losaria · 16問 · 1年前

    exam

    exam

    16問 • 1年前
    Hannah Angelique Losaria

    spec

    spec

    Hannah Angelique Losaria · 41問 · 1年前

    spec

    spec

    41問 • 1年前
    Hannah Angelique Losaria

    midterm

    midterm

    Hannah Angelique Losaria · 55問 · 1年前

    midterm

    midterm

    55問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    Hannah Angelique Losaria · 54問 · 1年前

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    54問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    Hannah Angelique Losaria · 29問 · 1年前

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    29問 • 1年前
    Hannah Angelique Losaria

    DDS

    DDS

    Hannah Angelique Losaria · 33問 · 1年前

    DDS

    DDS

    33問 • 1年前
    Hannah Angelique Losaria

    hallucinogens

    hallucinogens

    Hannah Angelique Losaria · 22問 · 1年前

    hallucinogens

    hallucinogens

    22問 • 1年前
    Hannah Angelique Losaria

    non volatile poisons

    non volatile poisons

    Hannah Angelique Losaria · 42問 · 1年前

    non volatile poisons

    non volatile poisons

    42問 • 1年前
    Hannah Angelique Losaria

    endterm

    endterm

    Hannah Angelique Losaria · 63問 · 1年前

    endterm

    endterm

    63問 • 1年前
    Hannah Angelique Losaria

    q3 endterm

    q3 endterm

    Hannah Angelique Losaria · 17問 · 1年前

    q3 endterm

    q3 endterm

    17問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019

    mockboard 2019

    Hannah Angelique Losaria · 65問 · 1年前

    mockboard 2019

    mockboard 2019

    65問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019 II

    mockboard 2019 II

    Hannah Angelique Losaria · 39問 · 1年前

    mockboard 2019 II

    mockboard 2019 II

    39問 • 1年前
    Hannah Angelique Losaria

    問題一覧

  • 1

    gi transit, speed gastric emptying time

    prokinetic

  • 2

    prokinetic indications

    GERD, impaired gastric emptying, vagotomy, antrectomy, diabetic gastroperesis

  • 3

    cholinomimetic agents

    betanechol, neostigmine

  • 4

    muscarinic m3 receptor on myenteric plexus synapse

    betanechol

  • 5

    acetylcholinisterase inhibitor, ohilvie's syndrome

    neostigmine

  • 6

    acute colonic pseudoobstruction

    ogilvie's syndrome

  • 7

    substituted benzamines

    metoclopramide, domperidone, cisapride, erythromycin

  • 8

    blocks dopamine d2 receptor, anti nausea, antiemetic. includes prolactin, cholinergic smooth muscle stimulation

    metoclopramide, domperidone

  • 9

    methomoglobinemia

    metoclopramide

  • 10

    qt interval prolongation, cardiact arrest, sudden death

    domperidone

  • 11

    5ht4 agonist enteric neurons acetylcholine release 5ht3 antagonist

    cisapride

  • 12

    parkinsonism syndrome, restlessness

    metoclopramide

  • 13

    cardiac arrythmias

    cisapride

  • 14

    directly stimulates motilin receptor onset of migrating motor complex

    erythromycin

  • 15

    antipsychotic agents potent antiemetic and sedative properties inhibits dopamine and muscarinic antihistamine

    phenothiazine

  • 16

    dioperidol

    butyrophones

  • 17

    anti emetic due to dopaminergic blockade metoclopramide and trimethobenzamide dopamine receptor blockade

    butyrophones

  • 18

    lorazepam and diazepam

    benzodiazepines

  • 19

    before the initiation of cemotherapy to reduce anticipatory vomiting

    benzodiazepines

  • 20

    dronabinol

    cannabinoids

  • 21

    major psychoactive compound

    synthetic-9-tetrahydrocannabinoid

  • 22

    appetite stimulant

    cannabinoids

  • 23

    dexamethasone, methylprednisolone

    corticosteroids

  • 24

    tx of chemo induced vomiting

    corticosteroids

  • 25

    prototypic muscarinic receptor antagonist most effective for motion sickness

    hyoscine

  • 26

    prophylaxis of motion sickness clear for tetranogenic potential

    dicyclomine

  • 27

    h2 antihistamines

    cetirizine, cyclizine, dimehydrimate, diphenhydramine

  • 28

    motion sickness, lesser morning sickness anti emetic properties is base on anti cholinergic, anti histamine and sedation

    h2 antihistamines

  • 29

    potent antiemetics. blocks d2 receptor in ctz antagonize amorphin induced vomiting

    neuroleptics

  • 30

    difficult or infrequent passage of stools

    constipation

  • 31

    tx of constipations

    anticholinergic, antacid, narcotics

  • 32

    laxatives

    bulk forming, osmotic, stimulant, stool surfactant

  • 33

    indigestible, hydrophillic colloids that absorbs water forming or bulky emollient gels

    bulk laxatives

  • 34

    do not give to pc with crohns diseas, obstruction, intestinal strictures

    bulk laxatives

  • 35

    natural plant producs

    psylium and methylcellulose

  • 36

    synthetic fibers

    polycarbophil

  • 37

    soluble but not absorbable compound. results to increase stool liquidation

    saline and osmotic laxatives

  • 38

    purgatives

    magnesium citrate, sodium sulfate, milk of magnesia

  • 39

    magnesium oxide

    milk of magnesia

  • 40

    reduce ammonia levels in hepatic encephalopathy

    lactulose

  • 41

    rectal burning

    glycerin

  • 42

    sorbitol

    non absorbable

  • 43

    complete colonic cleansing before git endoscopy

    polythylene glycol

  • 44

    induce bowel movements through direct stimulation of enteric ns, colonic electrolyte, fluid secretion

    stimulant laxatives

  • 45

    not to be given in px with hpn, chf, and renal impairment

    saline

  • 46

    aloe, senna, cascara

    anthraquinone derivatives

  • 47

    side effects of anthraquinone derivatives

    melanosis coli, brown pigmentation, chronic use

  • 48

    diphenylmethane derivatives

    phenolphthalein, bisacodyl, castor oil

  • 49

    dulcolax

    bisacodyl

  • 50

    phased out in market due to cardiac toxicity

    phenolphthalein

  • 51

    hydrolyzed in small intestine local irritant that stimulates inyestinal motility

    castor oil

  • 52

    soften stool materials, permits h2o and lipides to penetrate

    stool surfactant agents

  • 53

    softeners

    stool surfactant agents

  • 54

    example of stool surfactants

    ducosate and glycerin supp

  • 55

    clear, viscous oil that lubricates fecal material

    mineral oil

  • 56

    cannot be given to patients with bloody diarrhea, fever, and systemic toxicity

    antidiarrheal

  • 57

    tx of fecal impaction and debilitated adults

    mineral oil

  • 58

    side effects of mineral oil

    aspiration, pneumonitis, impair absorption of fat-soluble vitamins

  • 59

    fat-soulble vitamins

    ADEK

  • 60

    mild to moderate acute diarrhea control diarrhea caused by IBS and IBD

    antidiarrheal

  • 61

    example of antidiarrheal

    opoiod anatgonist, kaolin and pectin, colloidal bismuth, ocreotide, bind salts and binding resins

  • 62

    examples of bile salt resins

    cholistyramine and colestipol

  • 63

    diarrhea caused by excess bile acids, crohn's disease and resection of terminal ileum

    cholistyramine

  • 64

    SE of bile salt resins

    bloating, flatulence, constipation, fecal impaction

  • 65

    half life of somatostatin

    3 minutes

  • 66

    half life of ocreotides

    1.5 hours

  • 67

    inhibits the secretion of gastrin, cholecystokinin, glucagon, growth hormone, insulin secretion, pancreatic polypeptide, vasoactive intestinal peptide, and 5ht3

    somatostatin and ocreotide

  • 68

    inhibition of endocrine tumor

    somatostatin and ocreotide

  • 69

    carceroid and VIPoma

    endocrine tumor

  • 70

    SE of somatostatin and ocreotide

    steatorrhea, abdominal pain, ADEK difficiency, nausea

  • 71

    blocks 5ht3 receptor in the affarebt neurons distention induced sensory and motor reflex activation colonic motility

    serotonin 5ht3 receptor antagonist

  • 72

    diarrhea predominant ibs

    serotonin 5ht3 receptor antagonist

  • 73

    adr of serotonin 5htr receptor antagonist

    constipation, ischemic collitis

  • 74

    inhibits muscarinic cholinergic receptor in the enteric plexus; smooth muscles

    antispasmodics

  • 75

    examples of antispasmodics

    dicyclomine, hyoscyamine, tegaserod

  • 76

    hyosyamine

    levsin

  • 77

    dicyclomine

    bentyl

  • 78

    resembles serotonin in structure

    tegaserod

  • 79

    tx for IBS with predominant constipation

    tegaserod

  • 80

    IBD

    inflammatory bowel disease

  • 81

    immune mediated chronic intestinal condition

    inflammatory bowel disease

  • 82

    backwash ileitis

    ulcerative colitis

  • 83

    involves the rectum, extends proximally to involve the colon

    ulcerative colitis

  • 84

    mouth to anus; rectum is spared

    crohn's disease

  • 85

    perirectal fistulas, fissures abscesses, anal stenosis

    crohn's disease

  • 86

    tx for crohn's disease

    aminosalicylates, azo compounds, mesalamine compounds

  • 87

    purine anti metabolite

    azathioprine and 6-mercaptopurine

  • 88

    glucocorticoids

    infliximab, tacrolimus, cyclosporine

  • 89

    mainstay of therapy for mild to moderate ulcerative colitis

    aminosalicylates

  • 90

    examples of azo compounds

    sulfasalazine, olsalazine, balsalazide

  • 91

    mesalamine compounds

    pentasa, asacol, rowasa

  • 92

    reduces absorption of the oarent drug from the small intestine

    azo compounds

  • 93

    resident bacteria cleanse the azo bonds by means of

    azoreductase enzyme

  • 94

    5 asa group are bound together

    sulfasalazine

  • 95

    bound to 4-aminobenzoyl-b-alanine secretory diarrhea

    olsalazine

  • 96

    contains time release microgranules

    pentasa

  • 97

    oated in ph-sensitive resinthat dissolves at ph7

    asacol

  • 98

    delivered at high concentration to the rectum and the sigmoid colon

    rowasa

  • 99

    side effect of mesalamin compounds

    entestinal nephritis

  • 100

    induction and maintenance of remission of UC and CD post operative prophylaxis of cd

    purine anti-metabolite